Loading...

NewsRoom

Bulk Drugs Sector May Soon See Flurry of Deals

India's bulk drug makers are likely to see an unprecedented deals spree over the next three months, with at least six transactions...
Read More

Covaxin Shot Recommended For Children In India

New Delhi: An expert panel on Tuesday recommended Covaxin - Bharat Biotech's COVID-19 vaccine - for use on children between the ag...
Read More

36% of USFDA's market authorisations in 2020 went to Indian drug-makers...

In what can be seen as an indication of the primacy of India’s pharma industry, 36 per cent of total market authorisation grante...
Read More

Sehat Sathi plans to enable over 25,000 medicine shops go online...

The app helps standalone pharma stores to go digital without any need for investment in technology

Sehat Sathi, a B2B a...
Read More

API price hike hits pharma units

A steep rise in the prices of raw materials, including active pharmaceutical ingredients (APIs), which are largely imported from C...
Read More

Intas Pharma launches oral Azacitidine for blood cancer patients...

Becomes India's first pharmaceutical company to launch oral therapy under Azadine-O brand

Intas Pharmaceuticals Ltd on ...
Read More

Merck in advanced talks to buy Acceleron Pharma - WSJ...

Merck & Co (MRK.N) is in advanced talks to acquire drugmaker Acceleron Pharma Inc (XLRN.O), the Wall Street Journal reported on Mo...
Read More

Zydus ropes in Shilpa Medicare to make ZyCoV-D vaccine substance...

Zydus will transfer the ZyCoV-D technology to Shilpa Medicare arm, Shilpa Biologicals Private Limited

Covid-19 vaccine ...
Read More